Concepedia

Celalettin Üstün

CÜ

Statistics

Publications

119

Citations

7.5K

H-Index

44

Active since

1997

Affiliations

University of Minnesota(Current)

Medical College of Wisconsin

The University of Texas MD Anderson Cancer Center

Fred Hutch Cancer Center

Memorial Sloan Kettering Cancer Center

Celalettin Üstün is an author at University of Minnesota specializing in medicine, hematology, and stem cell transplantation.

Publications per year

1997–2025

119

Publications

119

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes et al. · The Lancet Oncology · 2017 · 488 citations · Full text

Medicine, Oncology, Pharmacology +10

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott et al. · Blood · 2018 · 407 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +9

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Warren Fiskus, Yongchao Wang, Arun Sreekumar et al. · Blood · 2009 · 358 citations · Full text

Medicine, Oncology, Pharmacology +17

Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

Celalettin Üstün, Andreas Reiter, Bart L. Scott et al. · Journal of Clinical Oncology · 2014 · 185 citations · Full text

Medicine, Hematology, Immunology +17

1–5 of 119